Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

PTPI

Petros Pharmaceuticals (PTPI)

Petros Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:PTPI
日付受信時刻ニュースソース見出しコード企業名
2024/05/2113 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PTPIPetros Pharmaceuticals Inc
2024/05/1420 : 00GlobeNewswire Inc.Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros PharmaceuticalsNASDAQ:PTPIPetros Pharmaceuticals Inc
2024/01/1306 : 32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
2023/12/3006 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
2023/12/2906 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
2023/12/2707 : 07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTPIPetros Pharmaceuticals Inc
2023/12/2707 : 06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTPIPetros Pharmaceuticals Inc
2023/12/2707 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTPIPetros Pharmaceuticals Inc
2023/12/0106 : 07Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:PTPIPetros Pharmaceuticals Inc
2023/12/0106 : 05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PTPIPetros Pharmaceuticals Inc
2023/11/1607 : 11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTPIPetros Pharmaceuticals Inc
2023/11/1607 : 00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PTPIPetros Pharmaceuticals Inc
2023/10/0221 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
2023/09/2005 : 36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PTPIPetros Pharmaceuticals Inc
2023/09/1913 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PTPIPetros Pharmaceuticals Inc
2023/09/1606 : 16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PTPIPetros Pharmaceuticals Inc
2023/09/1605 : 22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
2023/08/2606 : 08Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PTPIPetros Pharmaceuticals Inc
2023/08/1606 : 03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
2023/08/1606 : 01Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PTPIPetros Pharmaceuticals Inc
2023/08/1506 : 03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTPIPetros Pharmaceuticals Inc
2023/08/1205 : 31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PTPIPetros Pharmaceuticals Inc
2023/07/2205 : 30Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PTPIPetros Pharmaceuticals Inc
2023/07/1405 : 41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
2023/04/2907 : 08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
2023/04/2907 : 05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
2023/04/1307 : 02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
2023/04/1307 : 01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
2023/04/1307 : 01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
2023/04/1307 : 01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTPI